Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
life sciences
marc goodman
3
×
national blog main
national top stories
svb leerink
allergan
biotech
drugs
eli lilly
new york blog main
new york top stories
abbvie
alder biopharmaceutical
alkermes
allopregnanolone
american academy of neurology
amgen
atogepant
biohaven
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brexanolone
brian abrahams
buprenorphine
calcitonin gene-related peptide
cariprazine
detroit blog main
detroit top stories
eptinezumab
erenumab
europe
europe blog main
europe top stories
What
drug
fda
medicine
new
won
alkermes
antipsychotic
approval
approved
arguments
benefits
big
brexanolone
caveats
class
commercialized
commonly
companies
competitors
decades
depression
designed
devastating
disorder
drugs
effect
fast
favor
gain
make
meeting
migraine
moms
neuro
offer
oks
oral
panel
partum
post
Language
unset
Current search:
" marc goodman "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take